Schedule 13D ownership disclosure
Melinta Therapeutics Inc
Security class unavailable · CUSIP: 58549G100
Event date: 2017-11-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 30.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-340988
- Form type
- SC 13D
- Filer
- MELINTA THERAPEUTICS, INC. /NEW/
- CIK
- CIK 1461993
- Filed
- Nov 13, 2017
- Reporting period
- Nov 03, 2017
- Description
- Schedule 13D beneficial ownership